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Acute severe pancreatitis is associated with a highmorbidity andmortality and frequently is accompanied by underlying pancreatic
parenchymal necrosis. Patients with pancreatic necrosis must be identified, because the morbidity and mortality rate in this
subgroup is much higher. Our objective was to compare the clinical outcomes of these patients based on the degree of pancreatic
necrosis. A total of 35 patients were noted to have pancreatic necrosis. These were divided into 2 groups based on extent of
necrosis: group A had less than 50% necrosis and group B had more than 50% necrosis. The rate of mortality (5% versus 40%)
was significantly higher in group B. The rate of organ dysfunction also rose along with the rates of other morbidities and variables
that were related to a patient’s hospital stay. Only APACHE II significantly correlated with the degree of necrosis, wherein the
chances of substantial necrosis rose by 20% with each unit increase of APACHE II score. APACHE II Score could be employed and
studied further prospectively to help identify patients with pancreatic necrosis.
1. Introduction
Acute pancreatitis is an inflammatory process that develops
from damage to pancreatic acinar cells, which is caused
by inappropriate activation of digestive enzymes within the
cells. The mechanisms by which diverse etiological factors
initiate an attack are unclear.
The wide range of clinical presentations is based on the
extent and severity of the inflammatory response. From a
mild event that is confined to the gland to necrosis of the
pancreas with attendant multiorgan dysfunction, increasing
severity is associated with increased morbidity and mortality
[1, 2]. Numerous approaches to estimate the severity of
an episode have been used, from clinical estimation and
biochemical markers to multivariable scoring systems. A
shortcoming of these methods is their inability to assess
the extent of injury to the pancreas and peripancreatic
tissues.
It is imperative that we identify patients with pancreatic
necrosis, because morbidity and mortality rates in this
subgroup are much higher [3, 4].
For the diagnosis of pancreatic parenchymal necrosis,
intravenous contrast-enhanced CT scan is the ideal imaging
method [5, 6]. The accepted criteria for the diagnosis of
pancreatic necrosis on CT are focal or diﬀuse zones of
nonenhanced pancreatic parenchyma, visualized during
an examination with intravenous administration of contrast
material.
In 1985, Balthazar et al. were the first to grade severity of
pancreatitis based on CT findings [7]. Pancreatic tissue that
has undergone necrosis typically encompasses the body or
tail and shows decreased or no enhancement on CT and is
surrounded by normally enhancing pancreatic tissue [8].
The focus of our study was to compare the predictive
value of the Acute Physiological Assessment and Chronic
Health Evaluation (APACHE II) system with CT-visualized
extent of pancreatic injury in severe necrotizing pancreatitis.
2. Methods
2.1. Data Collection. This report is a retrospective, descrip-
tive case series. Patients who were admitted to the hospital
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between January 1999 and June 2006 with a diagnosis
of acute pancreatitis were identified through the medical
records system, using the ICD 9 coding. The medical records
of all patients with documented pancreatic necrosis were
then reviewed. Data was collected using a standardized
questionnaire.
The percentage of pancreatic parenchymal necrosis was
calculated by an independent review of the CT scans by a
single radiologist (FM). Based on the extent of pancreatic
necrosis on the CT scan, the patients were divided into 2
groups (group A patients, having less than 50% necrosis,
and group B patients, having more than 50% necrosis). The
APACHE II score was calculated from the medical records.
Patients with incomplete records or missing CT scans were
excluded from the study.
Cardiovascular dysfunction was defined as hypotension
that required vasoactive medication; renal dysfunction as
serum creatinine levels greater than 2mg/dL; and respiratory
dysfunction as the need for mechanical ventilation or PaO2
levels of less than 60mmHg.
Data from reports of any cultures from surgery or fine
needle aspirates (FNAs) were also collected. Infected pancre-
atic necrosis was defined as the presence of microorganisms
in either culture. Other infections were not included in the
current study.
Patients who died during the hospital stay were included
in the mortality statistics.
2.2. Study Design. Clinical outcomes were compared
between groups A (minimal necrosis, i.e., <50%) and B
(substantial necrosis >50%). Also, factors were compared
between survivors and nonsurvivors using univariate and
multivariate analysis.
2.3. Data Collection and Statistical Analysis. A database was
developed using Microsoft Access 2000, and the results were
imported into SPSS, version 13.0. Frequencies, percentages,
means, and standard deviations were computed when it was
appropriate. The chi-square or Fisher’s exact test was used to
compare categorical variables while Student’s t-test was used
to compare continuous variables between the two groups. A
double-sided P value of less than 0.05 was considered to be
statistically significant. Parameters that diﬀered in survivors
and nonsurvivors by univariate analysis with a P value of 0.25
or less were entered into the logistic regression model, using
mortality as the dependent variable, to identify factors that
were independently related to mortality.
3. Results
A total of 1225 patients with a diagnosis of acute pancreatitis
were admitted to the hospital during this period. 315 patients
had an abdominal CT scan. Of them, 48 patients experienced
pancreatic necrosis. Due to incomplete data or missing CT
scans, 13 patients were excluded from further review.
3.1. Age and Sex Distribution. There were 19 (54.3%) males
and 16 (45.7%) females. The mean age was 51.6 years, and
the standard of deviation was 14.6 years (range 28–77 years).
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Figure 1: Rates of mortality in relation to the degree of pancreatic
necrosis.
3.2. Type of Admission. 26 (74.2%) patients were admitted
from the emergency room, 1 (2.9%) was an inpatient, and 7
(20%) were transferred from another hospital. Information
was unavailable for 1 patient.
3.3. History and Cause of Pancreatitis. The cause was identi-
fied as biliary and alcohol-related pancreatitis in 19 (54.3%)
and 4 (11.4%), respectively. The cause was unknown in the
remaining 12 patients (34.3%). Four patients (11.4%) had a
prior known history of pancreatitis.
3.4. Percentage Necrosis on CT Scan. Of the 35 patients, 20
(57.1%) had less than 50% necrosis and 15 (42.9%) had
more than 50% pancreatic necrosis. The remaining analysis
concerns these 2 groups (A and B, resp.).
3.5. Comparison of Characteristics between Groups A and B.
There was no significant diﬀerence in sex (P value—0.315)
or age distribution in the groups (A—50.1 ± 15.0; and B—
53.7 ± 14.0 years (P value—0.480)). The type of admission
(i.e., ER, inpatient, or from another hospital) also was similar
between groups (P value—0.467).
The prevalence of comorbidities (HTN, DM, IHD,
COPD, and others) was comparable (P value > 0.5). Timing
of the CT scan also was similar, wherein the overall mean ±
s.d. was 5.4 ± 4.7 days.
3.6. Rate of Mortality and Organ Dysfunction (Table 1). Seven
patients died due to necrotizing pancreatitis. As shown in
Table 1, 1 patient died in group A, and 6 patients (40%) died
in group B. The rate of mortality was significantly higher in
group B (P value —0.027; Figure 1).
The proportion of individuals who suﬀered from organ
dysfunction also rose as the extent of necrosis increased
(Table 1 and Figure 2).
3.7. Hospital Stay and Rate of Other Morbidities (Table 2).
Nearly half of the patients in group B required a stay in the
ICU during their admission (7.86 ± 14.4 days). In contrast,
only 2 patients from group A had to be transferred to the ICU
(0.9± 3.39 days).
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Table 1: Rate of mortality and organ dysfunction depending on the
extent of pancreatic necrosis.
Variable <50% >50% Total P value
Mortality
Yes 1 6 7
∗0.027
Fisher’s
% 5 40 20
No 19 9 28
% 95 60 80
Organ dysfunction
Cardiovascular
Yes 2 8 10
∗0.008
% 10 53.3 28.6
No 18 7.0 25.0
% 90 46.7 71.4
Renal
Yes 4 5 9
0.450
% 20 33.3 25.7
No 16 10.0 26.0
% 80 66.7 74.3
Respiratory
Yes 6 10 16
∗0.044
% 30 66.7 45.7
No 14 5.0 19.0
% 70 33.3 54.3
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Figure 2: Rates of organ dysfunction in relation to the degree of
pancreatic necrosis
The hospital stay, the stay in the special care unit, and
the duration that the patient had to be maintained NPO also
were protracted as the extent of necrosis increased (Table 2).
Formation of pseudocysts was observed more frequently
in group B. Surgery for pancreatic necrosis (necrosectomy)
was performed in 5 patients, 2 of whom died (both of them
had more than 50% pancreatic necrosis).
Infection in the pancreas (FNA or postoperative tissue)
was present in 6 patients. E. coli grew in 4 of 6 cases, Enter-
obacter in 2 of 6 cases, S. aureus in 2 of 6 cases, Enterococcus
in 1 of 6 cases, Acinitobacter in 1 of 6 cases, Pseudomonas in
1 of 6 cases, and Citrobacter Freundii in 1 of 6 cases. Of the 6
Table 2: Hospital stay and rate of other morbidities depending on
the extent of pancreatic necrosis.
Variable <50% >50% Total P value
Requiring ICU stay
Yes 2 8.0 10.0
∗0.008
% 10 53.3 28.6
No 18 7 25
% 90 46.7 71.4
Total hospital stay
Mean 14.8 35.3 23.2
∗0.004s.d. 8.04 28.5 21.5
Range 3–35 7–106 3–106
Special care unit stay
Mean 5.1 11.8 7.9
∗0.006s.d. 4.4 8.9 7.3
Range 0–18 2–32 0–32
NPO duration
Mean 9.0 22.0 14.1
∗0.008s.d. 6.6 19.2 14.3
Range 2–21 2–68 2–68
Presence of infection
Yes 4 2 6
0.667
% 20 13.3 17.1
No 16 13 29
% 80 86.7 82.8
Surgery done
Yes 2 3 5
0.627
% 10 20 16.7
No 18 12 30
% 90 80 83.3
Pseudocyst†
Yes 10 7 17
0.689
% 55.6 70.0 60.7
No 8 3 11
% 44.4 30.0 39.3
Need for readmission†
Yes 6 6 12
0.243
% 33.3 60.0 42.9
No 12 4 16
% 66.7 40.0 57.1
†Patients who died or were lost to follow-up excluded from the analysis for
pseudocysts and need for readmission.
patients, 4 had less than 50% necrosis, and 2 had more than
50% necrosis. Both of the latter cases were oﬀered surgery
and died during admission.
Secondary diabetes mellitus developed in 6 patients, 4
of whom had more than 50% necrosis. Pancreatic fistula
developed in 4 patients, 2 of whom were in group A and 2
in group B. Wound-related complications were noted in 3
patients, 2 of whom were in group B (1 in group A).
Readmission rates were higher in group B (60%) com-
pared with group A (33.3%). These rates excluded persons
who either died or were lost to follow-up.
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Table 3: Ranson and APACHE scores of the patients depending on
the degree of pancreatic necrosis.
Variable <50% >50% Total P value
Total Ranson’s score
Median 4.0 4.67 4.35
0.445s.d. 1.51 1.94 1.73
Range 2–6 2–7 2–7
APACHE score
Mean 6.4 10.4 8.1
∗0.018s.d. 5.29 3.52 5.0
Range 1–23 4–18 1–23
3.8. Ranson, APACHE II, and Extent of Necrosis (Table 3).
There was no significant diﬀerence in the Ranson score
between the 2 groups. APACHE II scores, however, were
much higher for patients with greater necrosis (P value
0.018).
3.9. Factors Predicting Outcome. In the univariate analysis,
the statistically significant factors (P value < 0.05) that
correlated with mortality were the APACHE II score at
admission, presence of CVS dysfunction, renal dysfunction,
and substantial necrosis (>50%). Presence of infection, the
need for surgery, Ranson score, and age had P values of less
than 0.25.
In the final model, the factors that had potential impor-
tance in predicting mortality were entered into the binary
logistic regression analysis, using death as the outcome
variable. The variables were age, APACHE II score at
admission, the presence of substantial necrosis, presence of
CVS dysfunction, and presence of renal dysfunction. No
variable reached statistical significance.
3.10. Factors Predicting of Necrosis. In the univariate analysis,
age, male gender, past history of pancreatitis, cause of
pancreatitis, and total Ranson did not reach statistical signif-
icance (P value > 0.25). Only APACHE II score at admis-
sion significantly correlated with necrosis (P value—0.04),
wherein the chances of substantial necrosis rose by 20% with
each unit increase of APACHE II score.
4. Discussion
Acute severe pancreatitis is a serious illness that has a high
probability of complications and significant mortality [9].
Because of its prognostic association, estimating the severity
is an important clinical task once the diagnosis is established.
Although they are diagnostic standards, serum amylase and
lipase do not determine severity. Clinical assessment alone
can overlook severe disease in many patients.
Diﬀerent approaches have been used estimate severity.
Serum markers, such as tumor necrosis factor (TNF), C-
reactive protein (CRP), polymorphonuclear elastase, methe-
malbumin, and pancreatic ribonucleases, have been evalu-
ated as predictors, but none has gained widespread accep-
tance [10–12].
Multivariable scoring systems are another strategy. The
first numeric system was proposed by Ranson et al. in 1974
for acute alcohol-induced pancreatitis and remains the most
commonly used system [13]. It has 11 parameters—5 that are
evaluated at admission and 6 after 48 hours. An increasing
score corresponds to an increasing risk of mortality. The
sensitivity and specificity of this scoring system range from
50% to 80%.
More recently, the Acute Physiological Assessment and
Chronic Health Evaluation (APACHE II) assessment and
monitoring system has become popular, because it is more
reliable [14–16]. A shortcoming of biochemical markers and
multivariable scoring systems, however, as noted earlier is
their inability to assess the extent of injury to the pancreas
and peripancreatic tissues.
In 1985, Balthazar and colleagues became the first
researchers to grade severity of pancreatitis based on CT
findings [4, 7], which subsequently have shown good
correlation between pancreatic parenchymal necrosis, length
of hospitalization, development of complications, and death
[17]. In a cohort of patients with severe acute pancreatitis
who were treated surgically, mortality was approximately 13
times more likely in persons in whom sterile necrosis was
present (P value 0.012 OR 13.704) [18].
We have attempted to refine the prognostic predictive
power of pancreatic necrosis by CT scan by dividing the
patients into 2 arbitrary groups based on percentage of
necrosis: greater or less than 50%.
A similar approach has been taken by Mortele and col-
leagues, where they scored the presence of pancreatic necrosis
only as “no necrosis,” “minimal necrosis,” or “substantial
necrosis,” thereby eliminating the arguably unnecessary sepa-
rate categorization of patients who have 30% to 50% necrosis
and patients who have more than 50% necrosis, because
no significant diﬀerence exists in morbidity and mortality
between these 2 groups [19, 20]. It also would help in simpler
classification of these patients in practical clinical situations.
As noted earlier, group B, with more than 50% necrosis on
CT scan, had a significantly diﬀerent clinical course and a
much highermorbidity andmortality rate. Total hospital stay
and ICU stay also were higher in this group.
5. Conclusions
(i) The rate of mortality (5% versus 40%) was signifi-
cantly higher in patients with higher degree of
necrosis.
(ii) Only APACHE II significantly correlated with the
degree of necrosis, wherein the chances of substantial
necrosis rose by 20% with each unit increase of
APACHE II score.
(iii) The rate of organ dysfunction also rose in patients
with more than 50% necrosis of the pancreas.
Other morbidities and variables that were related to
hospital stay also increased in individuals with higher
necrosis.
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(iv) APACHE II score could be employed and studied
further prospectively to help identify patients with
pancreatic necrosis.
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